Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,026.00
Bid: 12,008.00
Ask: 12,012.00
Change: 674.00 (5.94%)
Spread: 4.00 (0.033%)
Open: 11,890.00
High: 12,096.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

14 Jun 2021 20:14

COVID SCIENCE-Delta variant doubles risk of hospitalization; Novavax vaccine highly effective in large trial

By Nancy LapidJune 14 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Delta variant doubles risk of ...

Read more
14 Jun 2021 18:00

UK study finds vaccines offer high protection against hospitalisation from Delta variant

LONDON, June 14 (Reuters) - COVID-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England (PHE) showed on Monday.Prime M...

Read more
14 Jun 2021 15:00

CORRECTED-Delta variant doubles risk of COVID hospitalisation - Scottish study

(Corrects typographical error in paragraph 4 to show number hospitalised with Delta variant was 134, not 1234)LONDON, June 14 (Reuters) - The Delta coronavirus variant doubles the risk of hospitalisation compared with the previously dominant varia...

Read more
14 Jun 2021 15:00

Delta variant doubles risk of COVID hospitalisation - Scottish study

LONDON, June 14 (Reuters) - The Delta coronavirus variant doubles the risk of hospitalisation compared with the previously dominant variant in Britain, but two doses of vaccine still provide strong protection, a Scottish study found on Monday.The ...

Read more
13 Jun 2021 20:18

EMA official says AstraZeneca shots have good risk-benefit profile for over 60s

MILAN, June 13 (Reuters) - The head of the EU drug regulator's COVID-19 task force said on Sunday that AstraZeneca's coronavirus vaccine had a favourable risk-benefit profile for all age groups and particularly for those aged over 60.Italian news...

Read more
13 Jun 2021 15:04

'No fear' decision to limit AstraZeneca can hamper COVID-19 vaccinations-Italy PM

CARBIS BAY, England, June 13 (Reuters) - There is "no fear" that a decision not to use AstraZeneca COVID-19 shots on people aged under 60 will hamper the Italian vaccination campaign, Prime Minister Mario Draghi said on Sunday."The vaccination pla...

Read more
11 Jun 2021 22:30

Oxford vaccine inventors recognised in Queen's Birthday Honours

LONDON, June 11 (Reuters) - The Oxford University scientists who invented the AstraZeneca COVID-19 vaccine are among those to be honoured by Queen Elizabeth, among a number of recipients who played key roles in Britain's coronavirus response, the ...

Read more
11 Jun 2021 18:05

UPDATE 1-Italy halts AstraZeneca vaccine for under-60s

(Adds details, background)By Gavin JonesROME, June 11 (Reuters) - The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had received the shot died fr...

Read more
11 Jun 2021 16:11

Italy halts AstraZeneca vaccine for under-60s after teenager dies

ROME, June 11 (Reuters) - The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had taken the shot died from a blood clot.Camilla Canepa died on Thur...

Read more
11 Jun 2021 14:22

EU advises against Astra vaccine for people with blood vessel syndrome

EU advises against Astra vaccine for people with blood vessel syndrome

Read more
11 Jun 2021 14:20

UK medicine regulator looking at capillary leak syndrome precaution for AstraZeneca shot

LONDON, June 11 (Reuters) - Britain's MHRA medicine regulator is considering precautionary advice for people with a history of capillary leak syndrome but does not see a causal link with AstraZeneca's COVID-19 vaccine after the EU said it was a r...

Read more
11 Jun 2021 12:19

UPDATE 2-EU adds another rare blood condition as side effect of AstraZeneca shot

(Adds background on capillary lead syndrome, heart inflammation; BioNTech comment)By Pushkala Aripaka and Ludwig BurgerJune 11 (Reuters) - Europe's drug regulator on Friday identified another rare blood condition as a potential side effect of Astr...

Read more
11 Jun 2021 12:19

UPDATE 3-EU adds another rare blood condition as side effect of AstraZeneca shot

(Adds statements from AstraZeneca, MHRA)By Pushkala Aripaka and Ludwig BurgerJune 11 (Reuters) - Europe's drug regulator on Friday identified another very rare blood condition as a potential side effect of AstraZeneca's COVID-19 vaccine and said it...

Read more
11 Jun 2021 11:45

UK vaccines minister says Pfizer supply tight but on track for target

UK vaccines minister says Pfizer supply tight but on track for target

Read more
11 Jun 2021 07:37

UPDATE 3-G7 vaccine pledge is just a drop in the ocean, campaigners say

* G7 to pledge 1 billion vaccine doses* Campaigners say G7 too slow, lacks ambition* Britain to give 100 million doses* UK says some countries using vaccines to exert influence (Adds quotes from former UK PM Brown, Canadian pledge)By Kate Holton and...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.